ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The ULTIMA study is intended to prove that in patients with pulmonary embolism and a right
ventricular end diastolic diameter to left ventricular end diastolic diameter ratio ≥1 (RV/LV
ratio) will benefit from treatment with ultrasound accelerated thrombolysis (rt-PA) as
compared to unfractionated heparin anticoagulation. Specifically, at 24 hours the RV/LV ratio
will be significantly reduced in the treatment arm compared to the control arm.